A XM não fornece serviços a residentes nos Estados Unidos da América.

Dow, S&P flirt with record highs as chip stocks and retail data support



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Dow, S&P flirt with record highs as chip stocks and retail data support</title></head><body>

Retail sales rise 0.4% in September

TSMC gains after forecasting Q4 revenue jump

Elevance Health down after cutting annual profit forecast

Netflix falls ahead of results

Indexes up: Dow 0.33%, S&P 500 0.18%, Nasdaq 0.39%

Updates to mid-afternoon

By David French

Oct 17 (Reuters) -Wall Street benchmarks advanced onThursday, with the S&P 500 and the Dow hovering around recordhighs, as chip stocks surged on TSMC's upbeat forecast and stronger-than-expected monthly retail sales indicated a robust U.S. consumer.

Taiwan Semiconductor Manufacturing Co 2330.TW, the world's largest contract chipmaker, beat market estimates for profit and forecast a jump in fourth-quarter revenue, driven by demand for artificial intelligence chips.

The chipmaker's U.S.-listed shares TSM.N soared 11.6%, while AI-trade favorite and TSMC customer Nvidia NVDA.O gained 2.6%, touching a record high.

The optimism spread to other chip stocks, sending the broader Philadelphia SE Semiconductor index .SOX 2.2% higher.

Fresh U.S.data confirmedhealthy growth in the world's largest economy, while keeping bets on a 25-basis-point rate cut at the Federal Reserve's next meeting largely intact at 89.4%, according to CME's FedWatch.

U.S. retail sales increased 0.4% in September, slightly more than expected, while weekly jobless claims fell unexpectedly.

As of 2:05 p.m. ET, the Dow Jones Industrial Average was up 140.27 points, or 0.33%, at 43,217.97, on track for the fourth lifetime closing high in five sessions.

The S&P 500 .SPX rose 10.56 points, or 0.18%, to 5,853.03 points, within touching distance of its best ever finish.

The Nasdaq Composite .IXIC advanced 72.23 points, or 0.39%, to 18,439.31.

A broadly upbeat start to the third-quarter earnings season, strong economic data and the Fed kicking off its policy-easing cycle have pushed the Dow and the S&P 500 to fresh record highs, with the benchmark index close to the psychologically important 6,000 mark.

U.S. equity benchmarks have advanced in recent days even as U.S. Treasury yields have crept up. OnThursday, the yield on the benchmark 10-year note US10YT=TWEB rose 7.5 basis points to 4.091%.

Interest in U.S. equities will remain strong, Thierry Wizman, global FX & rates strategist at Macquarie Group, projected.

"The fact it's higher yields in the U.S. and the U.S. economy is doing well, much better than the rest of the world, there's still that foreign bid for U.S. stocks that's coming in, and I suspect that's not completely exhausted."

Some money which had chased potential economic stimulus measures in China is likely returning to U.S. assets, Wizman noted.

While the main benchmarks advanced for thesecond straight day, small cap indexes fell. The Russell 2000 .RUT and the S&P Small Cap 600<.SPCY> were down 0.3%, having bothclosed at their highestin nearly three years on Wednesday.

A majority of S&P 500 sectors were also in negative territory, includingrate-sensitive indexes such asutilities .SPLRCU and real estate <.SPLRCR>, which slipped 0.6% and 0.4%, respectively.

In earnings-related moves,insurer Travelers Companies TRV.N gained 8.1% after its third-quarter profit beat market expectations. Money manager Blackstone Group BX.N rose 7% to arecord high after its latest numbers also exceeded expectations.

However,health insurer Elevance Health ELV.N plummeted 12.1% after slashing its full-year profit forecast.

Shares of streaming giant Netflix NFLX.O, which is scheduled to report third-quarter earnings after the bell, fell 1.2%.



Reporting by Lisa Mattackal and Purvi Agarwal in Bengaluru and David French in New York; Editing by Pooja Desai and Richard Chang

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.